1) 坪田一男, 横井則彦 : 日本におけるドライアイの発展の歴史と変遷. あたらしい眼科 38 : 1367-1374, 2021.
2) 島崎潤 (ドライアイ研究会診断基準委員会) : ドライアイの定義と診断基準. 眼科 37 : 765-770, 1995.
3) 島崎潤, 坪田一男, 木下茂, 他 : 2006年ドライアイ診断基準. あたらしい眼科 24 : 181-184, 2007.
4) 島崎潤, 横井則彦, 渡辺仁, 他 : 日本のドライアイの定義と診断基準の改定 (2016年度版). あたらしい眼科 34 : 309-313, 2017.
5) Yokoi N, Georgiev GA : Tear-film-oriented diagnosis and therapy for dry eye. In Yokoi N (ed) : Dry eye syndrome : basic and clinical perspectives, pp.96-108, Future Medicine, London, 2013.
6) Yokoi N, Georgiev GA, Kato H, et al : Classification of fluorescein breakup patterns : A novel method of differential diagnosis for dry eye. Am J Ophthalmol 180 : 72-85, 2017.
7) Yokoi N, Georgiev GA : Tear film-oriented diagnosis and tear film-oriented Therapy for dry eye based on tear film dynamics. Invest Ophthalmol Vis Sci 9 : DES13-DES22, 2018.
8) Yokoi N, Georgiev GA : Tear-film-oriented diagnosis for dry eye. Jpn J Ophthalmol 63 : 127-136, 2019.
9) Argueso P : Glycobiology of the ocular surface : mucins and lectins. Jpn J Ophthalmol 57 : 150-155, 2013.
10) Wolffsohn JS, Arita R, Chalmers R, et al : TFOS DEWS II diagnostic methodology report. Ocul Surf 15 : 539-574, 2017.
11) Jones L, Downie LE, Korb D et al : TFOS DEWS II management and therapy report. Ocul Surf 15 : 575-628, 2017.
12) Toda I, Shimazaki J, Tsubota K : Dry eye with only decreased tear break-up time is sometimes associated with allergic conjunctivitis. Ophthalmology 102 : 302-309, 1995.
13) 山本雄士, 横井則彦, 東原尚代, 他 : Tear film breakup time (BUT) 短縮型ドライアイの臨床的特徴. 日眼会誌 116 : 1137-1143, 2012.
14) ドライアイ診療ガイドライン作成委員会 : ドライアイ診療ガイドライン. 日眼会誌 123 : 489-592, 2017.
15) Tsubota K, Yokoi N, Shimazaki J, et al : New perspectives on dry eye definition and diagnosis : A Consensus report by the Asia Dry Eye Society. Ocul Surf 15 : 65-76, 2017.
16) Tsubota K, Yokoi N, Watanabe H, et al : A new perspective on dry eye classification : proposal by the Asia dry eye society. Eye Contact Lens 46 : S2-S13, 2020.
17) Tsubota K, Pflugfelder SC, Liu Z, et al : Defining dry eye from a clinical perspective. Int J Mol Sci 21 : 9271, 2020.
18) Yokoi N, Kato H, Kinoshita S : Facilitation of tear fluid secretion by 3% diquafosol ophthalmic solution in normalhuman eyes. Am J Ophthalmol 157 : 85-92, 2014.
19) Yokoi N, Komuro A : Non-invasive methods of assessing the tear film. Exp Eye Res 78 : 399-407, 2004.
20) 大竹雄一郎, 山田昌和, 佐藤直樹, 他 : 点眼薬中の防腐剤による角膜上皮障害について. あたらしい眼科 8 : 1599-1603, 1991.
21) Nakamura M, Mishima H, Nishida T, et al : Binding of hyaluronan to plasma fibronectin increases the attachment of corneal epithelial cells to a fibronectin matrix. J Cell Physiol 59 : 415-422, 1994.
22) Nakamura M, Nishida T, Hikida M, et al : Combined effects of hyaluronan and fibronectin on corneal epithelial wound closure of rabbit in vivo. Curr Eye Res 13 : 385-388, 1994.
23) Yokoi N, Komuro A, Nishida K, et al : Effectiveness of hyaluronan on corneal epithelial barrier function in dry eye. Br J Ophthalmol 81 : 533-536, 1997.
24) Yokoi N, Kato H, Kinoshita S : The increase of aqueous tear volume by diquafosol sodium in dryeye patients with Sjogren's syndrome : a pilot study. Eye (Lond) 30 : 857-864, 2016.
25) Yokoi N, Sonomura Y, Kato H, et al : Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjogren's syndrome. Eye (Lond) 29 : 1204-1212, 2015.
26) Shigeyasu C, Hirano S, Akune Y, et al : Diquafosol tetrasodium increases the concentration of mucinlike substances in tears of healthy human subjects. Curr Eye Res 40 : 878-883, 2015.
27) Yokoi N, Bron AJ, Georgiev GA : The precorneal tear film as a fluid shell : the effect of blinking and saccades ontear film distribution and dynamics. Ocul Surf 12 : 252-266, 2014.
28) 七條優子, 中村雅胤 : 培養ヒト角膜上皮細胞におけるジクアホソルナトリムの膜結合型ムチン遺伝子の発現促進作用. あたらしい眼科 28 : 425-429, 2011.
29) Georgiev GA, Eftimov P, Yokoi N : Contribution of mucins towards the physical properties of the tear film : A modern update. Int J Mol Sci 5 : 20, 2019.
30) 山口昌彦, 坪田一男, 渡辺仁, 他 : 3%ジクアホソルナトリウム点眼液のドライアイを対象としたオープンラベルによる長期投与試験. あたらしい眼科 29 : 527-535, 2012.
31) Kato K, Takashima Y, Matsunaga K, et al : Effect of topical rebamipide on conjunctival goblet cell recovery after vitrectomy. Sci Rep 6 : 19516, 2016.
32) Korb DR, Greiner JV, Herman JP, et al : Lidwiper epitheliopathy and dry-eye symptoms in contact lens wearers. CLAO J 28 : 211-216, 2002.
33) Knop N, Korb DR, Blackie CA et al : The lid wiper contains goblet cells and goblet cell crypts for ocular surface lubrication during the blink. Cornea 31 : 668-679, 2012.
34) Kase S, Shinohara T, Kase M, et al : Effect of topical rebamipide on goblet cells in the lid wiper of human conjunctiva.Exp Ther Med 13 : 3516-3522, 2017.
35) 横井則彦 : 糸状角膜炎・上輪部角結膜炎. 島崎潤 (編) : 角結膜疾患の治療戦略, pp.277-290, 医学書院, 東京, 2016.
36) Kinoshita S, Awamura S, Nakamichi N, et al : Rebamipide Ophthalmic Suspension Long-term Study Group : A multicenter, open-label, 52-week study of 2% rebamipide (OPC-12759) ophthalmic suspension in patients with dry eye. Am J Ophthalmol 157 : 576-583, 2014.
37) Itakura H, Kashima T, Itakura M, et al : Topical rebamipide improves lid wiper epitheliopathy. Clin Ophthalmol 7 : 2137-2141, 2013.
38) 青木崇倫, 横井則彦, 加藤弘明, 他 : ドライアイに合併した糸状角膜炎の機序とその治療の現状. 日眼会誌 123 : 1065-1070, 2019.
39) Takeji Y, Urashima H, Aoki A, et al : Rebamipide increases the mucin-like glycoprotein production in corneal epithelial cells. J Ocul Pharmacol Ther 28 : 259-263, 2012.
40) Uchino Y, Woodward AM, Argueso P : Differential effect of rebamipide on transmembrane mucin biosynthesis in stratified ocular surface epithelial cells. Exp Eye Res 153 : 1-7, 2016.
41) Bron AJ, de Paiva CS, Chauhan SK, et al : TFOS DEWS II diagnostic methodology report. Ocul Surf 15 : 539-574, 2017.
42) Taniguchi J, Sharma A : Fluorometholone modulates gene expression of ocular surface mucins. Acta Ophthalmol 97 : e1082-e1088, 2019.